About This Study
Primary mediastinal B-cell lymphoma (PMBCL) is a type of cancer in the upper chest between the lungs and behind the breastbone. The purpose of this study is to find out how well the study drug, nivolumab, works for treating PMBCL.
Need volunteers diagnosed with newly diagnosed primary mediastinal B-cell lymphoma. Treatment on this study lasts about 4-6 months. Study team will discuss study details with you.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 2 - 100 years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- No reimbursement offered
Study Locations
- Greater Winston-Salem, NC